Rational design of attenuated animal vaccine genomes: Commercial opportunities for controlling Foot and Mouth Disease
Lead Research Organisation:
University of St Andrews
Department Name: Biology
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
People |
ORCID iD |
| Martin Ryan (Principal Investigator) |
| Description | Identification of a range of potential academic and industrial partners (vaccine producers) in China. |
| First Year Of Impact | 2018 |
| Sector | Agriculture, Food and Drink |
| Description | Live, attenuated FMDV vaccines |
| Organisation | Huvepharma |
| Country | Bulgaria |
| Sector | Private |
| PI Contribution | Expertise / FMDV repliocn clones - modification of FMDV replicon clones. |
| Collaborator Contribution | Pilot experiments funded by Huvepharma to explore the utility of the FMDV replicon systems for vaccine design. |
| Impact | None |
| Start Year | 2020 |